A Study to Evaluate the Efficacy and Safety of HLX10 in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer
研究单位：[1]Shanghai Henlius Biotech[2]Providence Medical Group,Anaheim,California,United States,92805[3]Research Site,Orange,California,United States,32763[4]Kaiser Permanente Research,Pasadena,California,United States,91101[5]Emad Ibrahim, MD, INC-Redlands Community,Redlands,California,United States,92373[6]Research Site,Santa Rosa,California,United States,95403[7]Renown Health,Reno,Nevada,United States,89502[8]Tricounty Hematology and Oncology Associates,Massillon,Ohio,United States,44646[9]Ascend Pharma Holdings,Houston,Texas,United States,77015[10]The University of Texas at Tyler,Tyler,Texas,United States,75701[11]Northwest Medical Specialties,Tacoma,Washington,United States,98405[12]Klinikum Klagenfurt am Wörthersee,Klagenfurt am Wörthersee,Austria,9020[13]Karl Landsteiner Institut für Lungenforschung und pneumologische Onkologie, c/o Klinik Floridsdorf Abteilung für Innere Medizin und Pneumologie,Wien,Austria,1210[14]The First Affiliated Hospital of Bengbu Medical College,Bengbu,Anhui,China,233099[15]Anhui Chest Hospital,Hefei,Anhui,China,230031[16]Cancer Hospital Chinese Academy of Medical Sciences,Beijing,Beijing,China,100021[17]Chinese PLA General Hospital,Beijing,Beijing,China,100038[18]Beijing Cancer Hospital,Beijing,Beijing,China,100142[19]The First Affiliated Hospital of Chongqing Medical,Chongqing,Chongqing,China,400016[20]Chongqing University Cancer Hospital,Chongqing,Chongqing,China,400030[21]Fujian Medical University Union Hospital,Fuzhou,Fujian,China,350001[22]Fujian Cancer Hospital,Fuzhou,Fujian,China,350011[23]1st Hospital Guangdong Pharma,Guangzhou,Guangdong,China,510000[24]Zhongshandaxuefushuzhongyiyuan,Guangzhou,Guangdong,China,510030[25]Peking University Shenzhen Hospital,Shenzhen,Guangdong,China,518036[26]The Second Affiliated Hospital of Guilin Medical University,Guilin,Guangxi,China,541100[27]Guangxi Medical University Affiliated Tumor Hospital,Nanning,Guangxi,China,530021[28]Gungzhouyikedaxuefushuzhongliuyiyuan,Guangzhou,Guangzhou,China,510095[29]Affiliated Hospital of Hebei University,Baoding,Hebei,China,071000[30]Cangzhou People's Hospital,Cangzhou,Hebei,China,061019[31]Tangshan People's Hospital,Tangshan,Hebei,China,063001[32]Harbin Medical University Cancer Hospital,Harbin,Heilongjiang,China,150000[33]Jiamusi Cancer Hospital,Jiamusi,Heilongjiang,China,154007[34]The First Affiliated Hospital of Henan University of Science and Technology,Luoyang,Henan,China,471000[35]The First Affiliated Hospital of Xinxiang Medical University,Xinxiang,Henan,China,453100[36]Henan Cancer Hospital,Zhengzhou,Henan,China,450008[37]The First Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan,China,450052[38]Hong Kong United Oncology Centre,Hong kong,Hong Kong,China,999077[39]Queen Elizabeth Hospital,Hong Kong,Hong Kong,China,999077[40]Queen Mary Hospital,Hong Kong,Hong Kong,China,999077[41]Taihe Hospital affliated of Hubei Universiry of Medicine,Shiyan,Hubei,China,442000[42]Wuhan Tongji Hospital,Wuhan,Hubei,China,430030[43]Zhongnan hospital of wuhan university,Wuhan,Hubei,China,430071[44]Hubei Cancer Hospital,Wuhan,Hubei,China,430079[45]Changde First People's Hospital,Changde,Hunan,China,415000[46]The Second Xiangya Hospita,Changsha,Hunan,China,410008[47]Hunan Cancer Hospital,Changsha,Hunan,China,410013[48]Xiangya Hospital Central South University,Changsha,Hunan,China,410013[49]The Affiliated Hospital of Inner Mongolia Medical University,Hohhot,Inner Mongolia,China,010000[50]Jiangsu Province Hospital,Nanjing,Jiangsu,China,210029[51]Xuzhou Central Hospital,Xuzhou,Jiangsu,China,221000[52]Jiangsu Subei people's Hospital,Yangzhou,Jiangsu,China,210008[53]First Affiliated Hospital of Gannan Medical University,Ganzhou,Jiangxi,China,341001[54]Ganzhou Cancer Hospital,Ganzhou,Jiangxi,China,341005[55]The First Affiliated Hospital of Nanchang University,Nanchang,Jiangxi,China,330006[56]Jilin Cancer Hospital,Changchun,Jilin,China,130000[57]The First Hospital of Jilin University,Changchun,Jilin,China,130
This study is a randomized, double-blind, multicenter, phase III clinical study to compare the clinical efficacy and safety of HLX10 + chemotherapy+ concurrent radiotherapy vs chemotherapy+ concurrent radiotherapy in subjects with Limited-Stage Small Cell Lung Cancer.
